Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The correlation of HLA-G with multiple sclerosis.
Pregnancy Does Not Prove Neuroprotective for Women with MS Who Stop Taking Natalizumab
Correction: An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Comparison of Intelligibility Measures for Adults with Parkinson's Disease, Multiple Sclerosis and Healthy Controls.
Cost-effectiveness of an adjustment group for people with multiple sclerosis and low mood: a randomized trial.
Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism.
PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions.
Teriflunomide for the treatment of multiple sclerosis.
An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis.
Cognition, cognitive dysfunction, and cognitive rehabilitation in multiple sclerosis.
Ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, inhibits proliferation and differentiation of th17 cells.
ShcA Regulates Late Stages of T Cell Development and Peripheral CD4+ T Cell Numbers.
Plant sterols: Friend or foe in CNS disorders?
Fatigue induced changes to kinematic and kinetic gait parameters following six minutes of walking in people with multiple sclerosis.
The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
Thrombotic processes in multiple sclerosis as manifestation of innate immune activation.
Use of fingolimod in patients with relapsing remitting multiple sclerosis in Kuwait.
Retrograde trans-synaptic degeneration in MS: A missing link?
Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments.
Diffusion MRI-based cortical complexity alterations associated with executive function in multiple sclerosis.
Hospital admission due to infections in multiple sclerosis patients.
Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis.
A Mutation in PMP2 Causes Dominant Demyelinating Charcot-Marie-Tooth Neuropathy.
Schwann cells and their transcriptional network: Evolution of key regulators of peripheral myelination.
Register-based incidence of multiple sclerosis in Brittany (north-western France), 2000-2001.
Pages
« first
‹ previous
…
551
552
553
554
555
556
557
558
559
…
next ›
last »